Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%)
< Home < Back

Dr. Reddy's Laboratories gets nod for emergency use Russia's covid-19 vaccine Sputnik V in India

Date: 13-04-2021

Dr. Reddy's Laboratories has received approval from expert panel for emergency use of Russia's covid-19 vaccine Sputnik V in the India, with certain conditions. The Drugs Controller General of India (DCGI) will take a final call on the recommendation. If approved, it will be the third covid-19 vaccine to be available in India. The vaccine would be imported from Russia for emergency use in the country.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.